Supplementary Figure S6 from the Immune-Related 27-Gene Signature DetermaIO Predicts Response to Neoadjuvant Atezolizumab Plus Chemotherapy in Triple-Negative Breast Cancer | AMiner
Supplementary Figure S6 from the Immune-Related 27-Gene Signature DetermaIO Predicts Response to Neoadjuvant Atezolizumab Plus Chemotherapy in Triple-Negative Breast Cancer
Supplementary Figure 6. Comparison of TNBC subtype classification systems. A) Sankey plot showing the overlap between the TNBC subtype classification according to Ring and colleagues and the original TNBCtypes from Lehmann and colleagues B) pCR rate by Lehmann TNBCtypes and treatment arm.